Literature DB >> 33763709

Functional evaluation of a recombinant fungal immunomodulatory protein from L. rhinocerus produced in P. pastoris and E. coli host expression systems.

Udochukwu Camillius Ejike1, Chong Joo Chan1, Crystale Siew Ying Lim1, Renee Lay Hong Lim2.   

Abstract

Fungal immunomodulatory proteins (FIPs) are bioactive proteins with immunomodulatory properties. We previously reported the heterologous production in Escherichia coli of FIP-Lrh from Tiger milk mushroom (Lignosus rhinocerus) with potent cytotoxic effect on cancer cell lines. However, protein produced in E. coli lacks post-translational modifications and may be contaminated with lipopolysaccharide (LPS) endotoxin. Therefore, in this study, yFIP-Lrh produced in Pichia pastoris was functionally compared with eFIP-Lrh produced in E. coli. Expression construct of FIP-Lrh cDNA in pPICZα was generated, transformed into P. pastoris X-33 and Mut+ transformants were verified by colony PCR. Induction with 0.5% or 1% methanol resulted in a secreted 13.6 kDa yFIP-Lrh which was subsequently purified and verified using LCMS/MS analysis. Size exclusion chromatography confirmed eFIP-Lrh as a homodimer whereas the larger size of yFIP-Lrh may indicate post-translational modification despite negative for glycoproteins staining. At lower concentration (4-8 μg/mL), yFIP-Lrh induced significantly higher Th1 (IFN-γ, TNF-α) and Th2 (IL-6, IL-4, IL-5, IL-13) cytokines production in mice splenocytes, whereas 16 μg/mL eFIP-Lrh induced significantly higher pro-inflammatory cytokines (TNF-α, IL-6, IL-10), possibly due to higher residual LPS endotoxin (0.082 EU/mL) in eFIP-Lrh compared to negligible level in yFIP-Lrh (0.001 EU/mL). Furthermore, yFIP-Lrh showed higher cytotoxic effect on MCF-7 and HeLa cancer cells. Since both recombinant proteins of FIP-Lrh have the same peptide sequence, besides glycosylation, other post-translational modifications in yFIP-Lrh may account for its enhanced immunomodulatory and anti-proliferative activities. In conclusion, P. pastoris is preferred over E. coli for production of a functionally active yFIP-Lrh devoid of endotoxin contamination. KEY POINTS: • FIP-Lrh can induced production of Th1 and Th2 cytokines by mouse splenocytes. • Higher cytotoxic effect on cancer cells observed for yeast compared to E. coli produced FIP-Lrh. • P. pastoris allows production of an endotoxin-free and functionally active recombinant FIP-Lrh.

Entities:  

Keywords:  Cytotoxicity; Endotoxin; Fungal immunomodulatory protein; Lignosus rhinocerus; Recombinant protein

Mesh:

Substances:

Year:  2021        PMID: 33763709     DOI: 10.1007/s00253-021-11225-x

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  17 in total

1.  Assessment of bioaerosols and inhalable dust exposure in Swiss sawmills.

Authors:  Anne Oppliger; Sophie Rusca; Nicole Charrière; Trinh Vu Duc; Pierre-Olivier Droz
Journal:  Ann Occup Hyg       Date:  2005-02-07

2.  A 1.7A structure of Fve, a member of the new fungal immunomodulatory protein family.

Authors:  Palasingam Paaventhan; Jeremiah S Joseph; See Voon Seow; Shai Vaday; Howard Robinson; Kaw Yan Chua; Prasanna R Kolatkar
Journal:  J Mol Biol       Date:  2003-09-12       Impact factor: 5.469

Review 3.  Fungal immunomodulatory proteins: characteristic, potential antitumor activities and their molecular mechanisms.

Authors:  Qi-Zhang Li; Yu-Zhang Zheng; Xuan-Wei Zhou
Journal:  Drug Discov Today       Date:  2018-09-25       Impact factor: 7.851

4.  Optimization of the fermentation parameters for the production of Ganoderma lucidum immunomodulatory protein by Pichia pastoris.

Authors:  Pei-Wen Mao; Liu-Dingji Li; Yu-Liang Wang; Xiao-Hui Bai; Xuan-Wei Zhou
Journal:  Prep Biochem Biotechnol       Date:  2019-12-17       Impact factor: 2.162

5.  Guideline for validation of the LAL test as an end-product endotoxin test for human and biological drug products.

Authors:  T E Munson
Journal:  Prog Clin Biol Res       Date:  1985

Review 6.  Recent status and prospects of the fungal immunomodulatory protein family.

Authors:  Qi-Zhang Li; Xue-Fei Wang; Xuan-Wei Zhou
Journal:  Crit Rev Biotechnol       Date:  2011-06-09       Impact factor: 8.429

Review 7.  Strategies for the production of recombinant protein in Escherichia coli.

Authors:  Gopal Jee Gopal; Awanish Kumar
Journal:  Protein J       Date:  2013-08       Impact factor: 2.371

8.  Biochemical and functional characterization of recombinant fungal immunomodulatory proteins (rFIPs).

Authors:  Shanna Bastiaan-Net; Wasaporn Chanput; Amelie Hertz; Romy D Zwittink; Jurriaan J Mes; Harry J Wichers
Journal:  Int Immunopharmacol       Date:  2012-11-19       Impact factor: 4.932

9.  Lactococcus lactis harbouring Ara h 2.02 alleviates allergen-specific Th2-associated responses in sensitized mice.

Authors:  C J Chan; Y S Yong; A A L Song; R Abdul Rahim; L L A In; R L H Lim
Journal:  J Appl Microbiol       Date:  2019-12-13       Impact factor: 3.772

10.  High-Yield Production in Escherichia coli of Fungal Immunomodulatory Protein Isolated from Flammulina velutipes and Its Bioactivity Assay in Vivo.

Authors:  Xianghui Kong; Jiechi Zhang; Xue Han; Piqi Zhang; Xiaodong Dai; Jianing Liu; Xinxin Zhang; Imshik Lee; Shenkui Liu
Journal:  Int J Mol Sci       Date:  2013-01-24       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.